Treatment Preferences among Health Care Providers in the United States in Selecting Disease Modifying Therapies for Multiple Sclerosis: A Discrete Choice Experiment Study

Home / Intelligence / Scientific Publications / Treatment Preferences among Health Care Providers in the United States in Selecting Disease Modifying Therapies for Multiple Sclerosis: A Discrete Choice Experiment Study

Autoimmune screening panel (ASP) is routinely ordered as a part of diagnostic work-up in people with suspected multiple sclerosis (MS). However, data on prevalence and significance of ASP seropositivity in MS is scarce.

Authors

D. Bandari, M. Adamson, M. Bowman, A. Gutierrez, A. Athavale, B. Oak, N. Hadker, F. Branco, C. Geremakis, J. B. Lewin, S. L. Shankar

Journal

ECTRIMS 2022

Related Intelligence